However, the major genetic determinant underlying HPAH are germline heterozygous mutations of the BMPR2 gene on chromosome 2q33 that account for approximately 80% of patients with a known family history of PAH and 20% of apparently sporadic cases [9], [10]. Here, BMPR2 is linked to pulmonary arterial hypertension.